Springer Seminars in Immunopathology

, Volume 7, Issue 1, pp 3–7 | Cite as

Twenty-five years of immunosuppression

  • Robert S. Schwartz


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Alm YS, Harrington WJ, Simon SR, Mylvaganam R, Pall LM, So AG (1983) Danazol for the treatment of idiopathic thrombocytopenia purpura. N Engl J Med 308: 1396PubMedGoogle Scholar
  2. 2.
    Boldogh I, Beth E, Huang ES, Kyalwazi SK, Giraldo G (1981) Kaposi's sarcoma. IV. Detection of CMV DNA, CMV RNA and CMNA in tumor biopsies. Int J Cancer 28: 469PubMedGoogle Scholar
  3. 3.
    Calne RY (1963) Renal transplantation. Williams and Wilkins, BaltimoreGoogle Scholar
  4. 4.
    Chang RS, Lewis JP, Reynolds RD, Sullivan MJ, Newman J (1978) Oropharyngeal excretion of Epstein-Barr virus by patients with lymphoproliferative disorders and by recipients of renal homografts. Ann Intern Med 88: 34PubMedGoogle Scholar
  5. 5.
    Dameshek W, Schwartz R (1960) Treatment of certain “autoimmune” diseases with antimetabolites; a preliminary report. Trans Assoc Am Physicians 73: 113PubMedGoogle Scholar
  6. 6.
    Durack DT (1981) Opportunistic infections and Kaposi's sarcoma in homosexual men. N Engl J Med 305: 1465PubMedGoogle Scholar
  7. 7.
    Friou GJ, Finch SC, Detre KD (1958) Interaction of nuclei with globulin from lupus erythematosus serum demonstrated with fluorescent antibody. J Immunol 80: 324PubMedGoogle Scholar
  8. 8.
    Hahn B, Ebling FM (1983) Suppression of NZB/NZW murine neprhritis by administration of a syngeneic monoclonal antibody to DNA — possible role of anti-idiotypic antibodies. J Clin Invest 71: 1728PubMedGoogle Scholar
  9. 9.
    Hanto DW, Frizzera G, Gajl-Peczalska KJ, Sakamoto K, Purtilo DT, Balfour HH Jr, Simmons RL, Najarian JS (1982) Epstein-Barr virus-induced B cell lymphoma after renal transplantation. N Engl J Med 306: 903Google Scholar
  10. 10.
    Hauser SL, Dawson DM, Lehrich JR, Beal ME, Kevy SV, Propper RD, Mills JA, Weiner HL (1983) Intensive immunosuppression in multiple sclerosis. N Engl J Med 308: 173PubMedGoogle Scholar
  11. 11.
    Hertel BF, Rosai J, Delmer LP, Simmons RL (1977) Lymphoproliferative disorders in organ transplant recipients. Lab Invest 36: 340Google Scholar
  12. 12.
    Hoover R, Fraumeni JF Jr (1973) Risk of cancer in renal transplant recipients. Lancet 2: 55PubMedGoogle Scholar
  13. 13.
    Isenberg DA, Morrow WJW, Snaith ML (1982) Methylprednisolone pulse therapy in the treatment of systemic lupus erythematosus. Ann Rheum Dis 41: 347PubMedGoogle Scholar
  14. 14.
    Jerne NK (1974) Towards a network theory of the immune system. Ann Immunol 125C: 373Google Scholar
  15. 15.
    Kotzin BL, Strober S, Engleman EG, Calin A, Hoppe RT, Kansas GS, Terrell CP, Kaplan HS (1981) Treatment of intractable rheumatoid arthritis with total lymphoid irradiation. N Engl J Med 305: 969PubMedGoogle Scholar
  16. 16.
    Louie S, Daoust PR, Schwartz R (1980) Immunodeficiency and the pathogenesis of non-Hodgkin's lymphoma. Semin Oncol 7: 267PubMedGoogle Scholar
  17. 17.
    Malaviya AN, Many A, Schwartz RS (1968) Treatment of dermatomyositis with methotrexate. Lancet 2: 485PubMedGoogle Scholar
  18. 18.
    Morrow WJW, Youinou P, Isenberg DA, Snaith ML (1983) Systemic lupus erythematosus: 25 years of treatment related to immunopathology. Lancet 2: 206PubMedGoogle Scholar
  19. 19.
    Penn I (1979) Kaposi's sarcoma in organ transplant recipients. Transplantation 27: 8PubMedGoogle Scholar
  20. 20.
    Okada S, Strober S (1982) Generation of antigen-specific suppressor cells in the mixed leukocyte reaction after the addition of spleen cells from adult mice given total lymphoid irradiation. J Exp Med 156: 522PubMedGoogle Scholar
  21. 21.
    Palacios R (1982) Mechanism of T cell activation: role of functional relationship of HLA-DR antigens and interleukins. Immunol Rev 63: 73PubMedGoogle Scholar
  22. 22.
    Salama A, Mueller-Eckhardt C, Kiefel V (1983) Effect of intravenous immunoglobulin in immune thrombocytopenia. Lancet 2: 193PubMedGoogle Scholar
  23. 23.
    Schwartz RS, Stack J, Dameshek W (1958) The effect of 6-mercaptopurine on antibody production. Proc Soc Exp Biol Med 99: 164PubMedGoogle Scholar
  24. 24.
    Shoenfeld Y, Hsu-Lin SC, Gabriels JE, Silberstain LE, Furie BC, Furie B, Stollar BD, Schwartz RS (1982) Production of autoantibodies by human-human hybridomas. J Clin Invest 70: 205PubMedGoogle Scholar
  25. 25.
    Shoenfeld Y, Schwartz RS (1983) Medical progress. Immunologic and geneticfactors in autoimmune diseases. N Engl J Med (in press)Google Scholar
  26. 26.
    Strauch B, Andrews L, Siegel N, Miller G (1974) Oropharyngeal excretion of Epstein-Barr virus by renal transplant recipients and other patients treated with immunosuppressive drugs. Lancet 1: 234PubMedGoogle Scholar
  27. 27.
    Tenenbaum J, Urowitz MB, Keystone EC, Dwosh IL, Curtis JE (1979) Leucapheresis in severe rheumatoid arthritis. Ann Rheum Dis 38: 40PubMedGoogle Scholar

Copyright information

© Springer-Verlag 1984

Authors and Affiliations

  • Robert S. Schwartz
    • 1
  1. 1.Hematology-Oncology DivisionDepartment of Medicine, New England Medical CenterBostonUSA

Personalised recommendations